High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials

[1]  R. Preston,et al.  The protein C pathways , 2022, Current opinion in hematology.

[2]  Tomoko Matsumoto,et al.  Comprehensive blood coagulation potential in patients with acquired hemophilia A: retrospective analyses of plasma samples obtained from nationwide centers across Japan , 2021, International journal of hematology.

[3]  K. Nogami,et al.  Ex Vivo Prediction of Comprehensive Coagulation Potential Using Simulated Blood Concentrations of Emicizumab in Patients with Acquired Hemophilia A , 2021, Thrombosis and Haemostasis.

[4]  Y. Ogawa,et al.  Overshoot of FVIII activity in patients with acquired hemophilia A who achieve complete remission , 2020, International Journal of Hematology.

[5]  K. Nogami,et al.  Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis , 2019, International Journal of Hematology.

[6]  J. Ahluwalia,et al.  Elevated Von Willebrand Factor Antigen Levels are an Independent Risk Factor for Venous Thromboembolism: First Report from North India , 2019, Indian Journal of Hematology and Blood Transfusion.

[7]  K. Nogami,et al.  Possible assessment of coagulation function and haemostasis therapy using comprehensive coagulation assays in a patient with acquired haemophilia A , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  Tomoko Matsumoto,et al.  First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin , 2017, International Journal of Hematology.

[9]  K. Nogami.  The utility of thromboelastography in inherited and acquired bleeding disorders , 2016, British journal of haematology.

[10]  Massimo Franchini,et al.  Acquired haemophilia A: A 2013 update , 2013, Thrombosis and Haemostasis.

[11]  Tomoko Matsumoto,et al.  Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis , 2013, Thrombosis and Haemostasis.

[12]  O. Rawley,et al.  Elevated factor VIII levels and risk of venous thrombosis , 2012, British journal of haematology.

[13]  P. James,et al.  von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies , 2012, American journal of hematology.

[14]  J. Esser,et al.  Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) , 2012, Journal of thrombosis and haemostasis : JTH.

[15]  S. Machin,et al.  Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study. , 2012, Thrombosis research.

[16]  P. Collins,et al.  Management of acquired haemophilia A , 2011, Journal of thrombosis and haemostasis : JTH.

[17]  B. Dahlbäck,et al.  Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue. , 2011, Blood.

[18]  J. O’Donnell,et al.  Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  Tomoko Matsumoto,et al.  A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A , 2009, International journal of hematology.

[20]  N. Key,et al.  Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram , 2009, Thrombosis and Haemostasis.

[21]  G. Lippi,et al.  Acquired factor VIII inhibitors. , 2008, Blood.

[22]  T. Baglin,et al.  Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. , 2007, Blood.

[23]  A. Blann.  Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years , 2005, Thrombosis and Haemostasis.

[24]  L. Cristina,et al.  High plasma levels of factor VIII and risk of recurrence of venous thromboembolism , 2004, British journal of haematology.

[25]  J. Astermark,et al.  Factor VIII Inhibitor-Bypassing Agents Act by Inducing Thrombin Generation and Can Be Monitored by a Thrombin Generation Assay , 2003, Pathophysiology of Haemostasis and Thrombosis.

[26]  H. Coenraad Hemker,et al.  Calibrated Automated Thrombin Generation Measurement in Clotting Plasma , 2003, Pathophysiology of Haemostasis and Thrombosis.

[27]  J. Delgado,et al.  Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors , 2003, British journal of haematology.

[28]  A. Folsom,et al.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.

[29]  M Stain,et al.  High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. , 2000, The New England journal of medicine.

[30]  G. C. van den Bos,et al.  Pump-induced platelet aggregation in albumin-coated extracorporeal systems. , 1999, The Journal of thoracic and cardiovascular surgery.

[31]  R. Kaufman,et al.  Regulation of Factor VIII Expression and Activity by von Willebrand Factor , 1999, Thrombosis and Haemostasis.

[32]  A. Nomura,et al.  Identification of the Binding Site for an Alloantibody to von Willebrand Factor which Inhibits Binding to Glycoprotein Ib within the Amino-terminal Region Flanking the A1 Domain , 1999, Thrombosis and Haemostasis.

[33]  M. Laffan,et al.  The influence of factor VIII on measurement of activated protein C resistance. , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[34]  Ç. Turgan,et al.  Circulating thrombomodulin as a molecular marker of endothelium damage in renal transplant recipients. , 1996, Nephron.

[35]  H. Hemker,et al.  Continuous Registration of Thrombin Generation in Plasma, Its Use for the Determination of the Thrombin Potential , 1993, Thrombosis and Haemostasis.

[36]  P. Fay,et al.  Regulation of blood coagulation by the protein C system , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  A. Dorner,et al.  The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII. , 1991, The Journal of biological chemistry.

[38]  S. Kimura,et al.  Plasma thrombomodulin in health and diseases. , 1990, Blood.

[39]  S. Mehta,et al.  Acquired haemophilia. , 1990, The Journal of the Association of Physicians of India.

[40]  G. Zampighi,et al.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. , 1981, Biochemistry.

[41]  D. Green,et al.  Proceedings: A more uniform measurement of factor VIII inhibitors. , 1975, Thrombosis et diathesis haemorrhagica.